Legend Biotech Corp - ADR

NASDAQ:LEGN   10:07:35 AM EDT
43.23
-1.16 (-2.61%)
Earnings Announcements

Legend Biotech Reports Third Quarter 2021 Financial Results

Published: 11/16/2021 13:45 GMT
Legend Biotech Corp - ADR (LEGN) - Legend Biotech Reports Third Quarter 2021 Financial Results and Recent Highlights.
Q3 Loss per Share $0.43.
Q3 Revenue $16.9 Million.
Q3 Earnings per Share View $-0.36 -- Refinitiv Ibes Data (analyst estimates).
Anticipates Submitting NDA to Japan Pharmaceuticals and Medical Devices Agency in Q4 2021 for Approval of Cilta-cel With Janssen.
Revenue is expected to be $13.13 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $11 Million
Next Quarter EPS Guidance is expected to be -$0.38

More details on our Analysts Page.